What is Seaport Therapeutics 's non-cash lease expense?

Seaport Therapeutics (SPTX) reported non-cash lease expense of $331K in Q1 2026.

What does non-cash lease expense mean?

Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.

Seaport Therapeutics SPTX Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

RepligenRGEN

$4.78M+6.5%

AppFolioAPPF

$560K+11.8%

CHE

ChemedCHE

$17.21M+2.0%

LAD

Lithia MotorsLAD

$24.3M+8.0%

ArchrockAROC

$1.16M-4.0%

Zillow Group, Inc.ZG

$2M0.0%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's non-cash lease expense?: Seaport Therapeutics (SPTX) reported non-cash lease expense of $331K in Q1 2026.
What does non-cash lease expense mean?: Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.